SCHEMBL7946252

SCHEMBL7946252

Cc1noc(NS(=O)(=O)c2cc(N)ccc2-c2ccc(CC(C)C)cc2)c1C

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 2/20 0.74
EDNRB P24530 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6777719 0.92 EDNRA (0.74) EDNRAEDNRB
SCHEMBL6767638 0.88 EDNRB (0.74) EDNRAEDNRB
SCHEMBL6772509 0.86 EDNRB (0.72) EDNRAEDNRB
SCHEMBL9088050 0.86 EDNRA (0.77) EDNRAEDNRB
SCHEMBL6778007 0.85 EDNRA (1.00) EDNRAEDNRB
SCHEMBL6771743 0.82 EDNRA (0.70) EDNRAEDNRB
SCHEMBL6768276 0.80 EDNRB (0.72) EDNRAEDNRB
SCHEMBL6773114 0.80 EDNRA (0.68) EDNRAEDNRB
SCHEMBL6771913 0.80 EDNRA (0.71) EDNRAEDNRB
SCHEMBL6767698 0.79 EDNRA (1.00) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569193-B1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists SQUIBB & SONS INC (US) 1997-02-26 EP claimed
EP-0569193-A1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists E.R. SQUIBB & SONS, INC. (US) 1993-11-10 EP claimed
WO-2001049289-A1 PHARMACEUTICAL AND VETERINARY USES OF ENDOTHELIN ANTAGONISTS TEXAS BIOTECHNOLOGY CORPORATION (US) 2001-07-12 WO disclosed
EP-0569193-B1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists SQUIBB & SONS INC (US) 1997-02-26 EP disclosed
EP-0569193-A1 N-isoxazole-phenylsulfonamide derivatives and their use as endothelin antagonists E.R. SQUIBB & SONS, INC. (US) 1993-11-10 EP disclosed